FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and may be used in medicine. The SLIT protein is applied in preparing a pharmaceutical composition for preparing or treating cartilage disorders.
EFFECT: invention enables preventing or treating the cartilage disorders effectively.
15 cl, 9 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW APPLICATION | 2004 |
|
RU2416426C2 |
| APPLICATION OF PAK INHIBITOR FOR ARTHROPATHY TREATMENT | 2004 |
|
RU2360696C2 |
| IMPLANT CONTAINING FGF-18 | 2015 |
|
RU2700414C2 |
| SELECTIVE ELIMINATION OF EROSION CELLS | 2012 |
|
RU2617056C2 |
| NEW PEPTIDE AND ITS APPLICATION | 2011 |
|
RU2525913C1 |
| SCHEME FOR USING FGF-18 COMPOUND | 2015 |
|
RU2700582C2 |
| STABLE AQUEOUS COMPOSITIONS OF PROTEIN MIA/CD-RAP | 2011 |
|
RU2588658C2 |
| SOLUTIONS AND METHODS FOR INHIBITING PAIN, CARTILAGE INFLAMMATION AND DESTRUCTION | 2000 |
|
RU2271825C2 |
| RECOMBINANT MOLECULES OF LUBRICIN AND THEIR USE | 2004 |
|
RU2376313C2 |
| RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING HAS2 AND LUBRICIN, SUITABLE IN TREATMENT OF OSTEOARTHRITIS AND SIMILAR JOINT DISEASES IN MAMMALS | 2017 |
|
RU2771490C2 |
